Immunowake
1 known investors
Find your way into Immunowake
Sign up to see every warm intro you have to Immunowake
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Immunowake team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ImmunoWake develops immunocytokine therapeutics that use targeted precision delivery to harness the anti-tumor potential of cytokines while reducing their systemic toxicity. The company is building a pipeline of immunocytokine drugs to treat cancer and autoimmune diseases.
Investors · 1
Frequently asked questions
- What does Immunowake do?
- ImmunoWake develops immunocytokine therapeutics that use targeted precision delivery to harness the anti-tumor potential of cytokines while reducing their systemic toxicity. The company is building a pipeline of immunocytokine drugs to treat cancer and autoimmune diseases.
- Who are Immunowake's investors?
- Immunowake's investors include Innovation Depot.